Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × brexucabtagene autoleucel × 30 days × Clear all

Phase

Status

Terminated 1 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Mantle-Cell 1

Interventions

pembrolizumab 29 Cyclophosphamide 18 Nivolumab 14 Paclitaxel 12 Cisplatin 11 Carboplatin 11 Radiotherapy 10 Gemcitabine 10 Surveys and Questionnaires 9 Standard of Care 8 Doxorubicin 8 Blood Specimen Collection 8 regorafenib 7 fludarabine 7 Oxaliplatin 7 Cetuximab 7 olaparib 6 Trastuzumab 6 Rituximab 6 Radiotherapy, Intensity-Modulated 6 Radiosurgery 6 Prednisone 6 Irinotecan 6 Ipilimumab 6 Fulvestrant 6 Fluorouracil 6 Docetaxel 6 Capecitabine 6 Androgen Antagonists 6 durvalumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02601313 2026-03-18

ZUMA-2

Gilead Sciences

Phase 2 Completed

105 enrolled 33 charts 2 FDA

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡